Navigation Links
Starion Instruments Launches Next-Generation Tissue Ligating Shears at the American College of Surgeons Clinical Congress
Date:10/10/2007

Building upon continued success, company offers new platform for general

surgical procedures

SUNNYVALE, Calif., Oct. 10 /PRNewswire/ -- Starion Instruments, a leading surgical device company, launched the TLS3 Tissue Ligating Shears at the American College of Surgeons 93rd Annual Clinical Congress in New Orleans this week. With the introduction of this new platform, Starion is building upon its success in the cardiovascular and otolaryngological markets to provide an essential solution for general surgical, gynecological and urological procedures.

Unlike conventional products that use monopolar, bipolar or ultrasonic energy as modes of operation, the TLS3 features Starion's proprietary tissue welding technology, which focuses thermal energy to simultaneously seal and divide soft tissue. This reduces thermal spread, which minimizes the risk of inadvertent collateral damage.

"Since the response to our technology by cardiovascular and otolaryngological surgeons has been extremely positive, we've taken this step to expand into the general surgical, gynecological and urological spaces," said Kirt Kirtland, president and chief executive officer of Starion Instruments. "With the TLS3, Starion now offers a complete platform that provides surgeons with the power and precision to quickly and effectively perform a variety of surgical procedures."

The TLS3 features enhanced sealing and dissecting capabilities, an ergonomic handle design, longer more tapered jaws, and two-speed finger control for unparalleled performance in open and minimally invasive surgical procedures. Three lengths, 14cm, 23cm and 35cm, provide improved sealing and dividing of larger vessels frequently encountered in general surgical, gynecological and urological procedures. Along with the TLS3, Starion is introducing a new Universal Power Supply that is compatible with the company's entire product line.

"The Starion TLS3 is the most versatile tissue sealing device on the market," said Dr. Paul G. Curcillo II, MD, F.A.C.S., associate professor and vice chair of the Department of Surgery and director of robotic and minimally invasive surgery, Drexel University College of Medicine. "Because the TLS3 has two active jaws, I can use it as a dissector and a grasper, as well as a cutter and sealer, which means I have fewer instrument exchanges through the abdominal wall during surgery. Additionally, the TLS3 has a comfortable handle design and a compact power supply making it easy for me to use and my operating room staff to set-up."

Starion will be showcasing the new TLS3 at the American College of Surgeons 93rd Annual Clinical Congress in New Orleans from October 7th - 11th at booth number 446.

About Starion Instruments

Starion Instruments designs, manufactures and sells surgical instruments that simultaneously seal and divide tissue during surgery, employing a proprietary tissue welding technology, which requires no electricity or ultrasonic energy across tissue. Starion products are in use worldwide in a variety of cardiac, general surgery, gynecology, otolaryngology and urology procedures. For more information, visit the company's website at http://www.starioninstruments.com.


'/>"/>
SOURCE Starion Instruments
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Musical Instruments Pleasing To The Ear But Rough On The Skin
2. Sterilization Of Dental Instruments Is Inadequate, Says Study
3. Contaminated Surgical Instruments Increase Risk Of Infections
4. Glaxo launches pills to help smokers quit in 7-12 weeks
5. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
6. Dr Reddy’s Laboratories launches Hyalosy
7. Serum Institute Launches New Tetanus-Diphtheria Vaccine
8. Scottish Health Minister Launches Organ Donor Plan
9. GlaxoSmithKline launches diabetes and cancer drugs
10. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
11. Pfizer Launches Viagra For Lung Disease In UK
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg ... Legal Elite. The attorneys chosen by their peers for this recognition are considered among ... Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite Hall ...
(Date:6/24/2016)... ... 2016 , ... EB Medicine presented its first-ever “Issue of ... in Ponte Vedra Beach, FL. The awards honor the outstanding work of leading ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the efforts ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology: